Natriuretic peptides in animal models of cardiovascular disease
Cardiovascular Endocrinology · 2014
DOI: 10.1097/xce.0000000000000025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Endocrinology, 2014. Verfasst von Dwaine S. Burley und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Natriuretic peptides play a major role in cardiovascular homeostasis, and much of our knowledge on this stems from animal studies looking into the genetic knockout or overexpression of natriuretic peptides or their biological target, the natriuretic peptide receptor. Genetic perturbation of the natriuretic peptide system in rodents causes systemic hypertension, cardiac fibrosis, left ventricular hypertrophy, and heart failure. Moreover, animal models of acute myocardial infarction and heart failure have demonstrated the therapeutic potential of exogenously administered natriuretic peptides in treating human acute coronary syndromes and heart failure. In this review, we hope to highlight the importance of animal models in helping us understand the biological function and consequence of the natriuretic peptide system in cardiovascular disease.
Zitieren
APA
Burley, D. S., Bice, J. S., & Baxter, G. F. (2014). Natriuretic peptides in animal models of cardiovascular disease. Cardiovascular Endocrinology. https://doi.org/10.1097/xce.0000000000000025
Vancouver
Burley DS, Bice JS, Baxter GF. Natriuretic peptides in animal models of cardiovascular disease. Cardiovascular Endocrinology. 2014. doi:10.1097/xce.0000000000000025
BibTeX
@article{Burley2014,
author = {Burley, Dwaine S. and Bice, Justin S. and Baxter, Gary F.},
title = {Natriuretic peptides in animal models of cardiovascular disease},
journal = {Cardiovascular Endocrinology},
year = {2014},
doi = {10.1097/xce.0000000000000025}
}
EUVIMED